SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharma - Quaterly Results

08 Aug 2023 Evaluate
The sales declined to Rs. 291.75 millions for the June 2023 quarter as compared to Rs. 311.32 millions during the corresponding quarter last year.A slender decline of -9.79% was recorded to Rs. 53.70  millions from Rs. 59.53 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 80.05 millions from 84.15 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 291.75 311.32 -6.29 291.75 311.32 -6.29 1367.49 1239.80 10.30
Other Income 10.37 11.43 -9.27 10.37 11.43 -9.27 51.23 49.49 3.52
PBIDT 80.05 84.15 -4.87 80.05 84.15 -4.87 354.90 322.04 10.20
Interest 0.74 0.87 -14.94 0.74 0.87 -14.94 3.67 4.35 -15.63
PBDT 79.31 83.28 -4.77 79.31 83.28 -4.77 351.23 317.69 10.56
Depreciation 5.00 5.35 -6.54 5.00 5.35 -6.54 22.59 18.99 18.96
PBT 74.31 77.93 -4.65 74.31 77.93 -4.65 328.64 298.70 10.02
TAX 20.61 18.40 12.01 20.61 18.40 12.01 82.58 75.74 9.03
Deferred Tax 0.59 -0.83 -171.08 0.59 -0.83 -171.08 -2.25 2.96 -176.01
PAT 53.70 59.53 -9.79 53.70 59.53 -9.79 246.06 222.96 10.36
Equity 44.13 45.89 -3.84 44.13 45.89 -3.84 44.13 45.89 -3.84
PBIDTM(%) 27.44 27.03 1.51 27.44 27.03 1.51 25.95 25.98 -0.09

Jenburkt Pharma Share Price

1050.40 24.80 (2.42%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×